Headache & Migraine
Neurology and Therapy · Urits et al. · 2020
Acupuncture and Its Role in the Treatment of Migraine Headaches
Weak
Limited
Moderate
Strong
41% vs 17%
Responders (≥50% reduction in frequency): acupuncture vs no treatment
50% vs 41%
Responders (≥50% reduction): real vs sham acupuncture
3-4 days/month
Reduction in migraine days
Study design sheet
- Evidence Still to Be Consolidated
- Design
- Narrative Review
- Duration
Analysis of multiple studies with follow-up of 3-12 months
Review of studies from 2014-2020
- OBJECTIVE
- Analyze evidence on the effectiveness of acupuncture in the treatment of migraine and chronic migraine
- WHO
- Adults with episodic or chronic migraine
- POINTS
- up to 365 specific points on the human body according to traditional Chinese medicine
- Results in numbers
- 41% vs 17%Responders (≥50% reduction in frequency): acupuncture vs no treatment
- 50% vs 41%Responders (≥50% reduction): real vs sham acupuncture
- 3-4 days/monthReduction in migraine days
- −0.16Lower risk of adverse effects than medication (risk difference)
- Outcome comparison
- Reduction in migraine frequency (≥50%)
- Real acupuncture: 50 of 100
- Sham acupuncture: 41 of 100
- Efficacy vs medication
- Acupuncture: 57 of 100
- Medication: 46 of 100
- Reduction in migraine frequency (≥50%)
What does this mean for you?
This review suggests that acupuncture may be a safe and useful option for certain patients with migraine, with a measurable effect on the frequency and duration of attacks. The authors indicate that the effect appears to require a minimum number of sessions (6-8). In one of the studies, the differences versus sham acupuncture were maintained at 3 months but not at 12 months. The authors stress that larger clinical trials and long-term follow-up are needed.
Article summary
Plain-language narrative summary
Migraine is a complex neurological condition that affects millions of people around the world, characterized by intense, disabling pain frequently accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. This disease represents the eighth largest cause of disability worldwide according to the World Health Organization, with a worldwide prevalence of 14.7%; in the USA, prevalence is 15.3%, higher in women (20.7%) than in men (9.7%). Many patients with migraine face difficulties in obtaining a correct diagnosis and access to the care they need, which leads clinicians and researchers to turn to other forms of treatment, such as acupuncture. In this context, acupuncture has emerged as a promising option for the treatment and prevention of migraine attacks.
This review study, conducted by researchers from renowned American medical institutions, aimed to analyze the current state of knowledge about the efficacy of acupuncture in the treatment of migraine and chronic migraine. The methodology consisted of a comprehensive review of the scientific literature, examining randomized clinical trials, meta-analyses, and systematic reviews published on the topic. The authors analyzed evidence on the mechanisms of action of acupuncture, its safety, and efficacy compared with conventional treatments, including preventive medications and those for relief of acute attacks.
The main results suggest that acupuncture may be a useful tool in the treatment of migraine. Multiple studies showed that acupuncture is superior to sham treatment ("sham" acupuncture) and, in many cases, at least as effective as conventional medications for the prevention of attacks. An important Cochrane systematic review, frequently cited as a reference in evidence-based medicine, reported that acupuncture significantly reduces both the duration and frequency of migraine episodes. Specific studies demonstrated that 41% of patients treated with acupuncture had a reduction of at least 50% in attack frequency, compared with only 17% of those who did not receive treatment.
When compared with sham acupuncture, true acupuncture showed efficacy in 50% of cases versus 41% of the control group. Another reported finding was that, compared with conventional medications, 57% of patients treated with acupuncture experienced significant reduction in attacks, against 46% of those who received only medication.
The clinical implications of these findings are significant for both patients and healthcare professionals. For patients, acupuncture may represent an alternative therapy that, according to the authors, may be beneficial to certain patients, especially for those who do not respond adequately to conventional medications or who experience undesirable side effects. Acupuncture is generally considered well tolerated and safe, and some studies reported minimal adverse effects. In addition to the direct benefits in reducing the frequency and intensity of pain, research has shown that patients treated with acupuncture had lower medical costs, a reduced risk of depression and anxiety — common comorbidities in migraine — and significant improvement in quality of life.
For healthcare professionals, these results suggest that acupuncture can be incorporated as part of an integrated approach in the treatment of migraine, offering physicians an additional tool in the therapeutic arsenal. The evidence suggests that acupuncture may be particularly useful for patients with chronic migraine, a condition frequently refractory to conventional treatments.
The study also revealed interesting aspects about the mechanisms by which acupuncture may exert its therapeutic effects. Research using functional magnetic resonance imaging has shown that the stimulation of specific acupuncture points activates brain regions related to pain processing, suggesting that the treatment may directly modulate the neural circuits involved in the pathophysiology of migraine. Studies with magnetic resonance spectroscopy demonstrated that acupuncture significantly increases levels of N-acetylaspartate in the thalamus, a marker of neural function, correlating with the reduction in pain intensity. These findings offer preliminary indications of the mechanisms by which acupuncture might act in migraine.
It is important to recognize the limitations identified in the review. Many studies presented significant heterogeneity in terms of acupuncture protocols used, treatment duration, study population, and methods of outcome assessment. This methodological variability makes it difficult to formulate definitive conclusions about the ideal standardization of treatment. In addition, some studies had relatively small samples and limited follow-up periods, highlighting the need for future research with greater methodological rigor.
The authors also noted that, although acupuncture demonstrates short-term efficacy, more studies are needed to definitively establish its long-term benefits; in one of the included trials (Wang et al., 2014), the differences versus sham acupuncture were maintained at 3 months but not at 12 months. Another important aspect is that the efficacy of acupuncture seems to depend on a minimum number of sessions (at least 6-8 sessions), but the ideal frequency of treatment or the most appropriate moment to begin the therapy has not yet been clearly established.
In conclusion, the authors state that many studies suggest acupuncture is a safe, helpful and available alternative therapy that may be beneficial to certain migraine patients, and that it is gaining attention as an addition to drug therapy because of its measurable effects on both the duration and frequency of migraine attacks. Nevertheless, they stress that further large-scale randomized controlled trials are warranted to consolidate these findings and support the clinical value of acupuncture, and that long-term follow-up of treated patients could elucidate the long-term effects of this treatment.
Strengths
- Includes large meta-analyses, such as Linde et al. (22 trials, 4,985 participants)
- Evidence of efficacy superior to sham acupuncture
- Favorable safety profile compared with medications
Limitations
- Heterogeneity in acupuncture protocols among studies
- Difficulty in standardizing points and frequency of treatment
- Need for more high-quality studies
- Variability in outcome measures across studies

Expert Commentary
Clinical Relevance
Chronic migraine remains one of the most frustrating challenges in physiatry and pain medicine: patients with frequent attacks, polymedicated, with adherence compromised by adverse effects of oral prophylactics. This narrative review, which brings together meta-analyses such as Linde et al. (22 trials, 4,985 participants), reinforces acupuncture as a concrete prophylactic alternative, not just an adjunct. The reduction of 3 to 4 migraine days per month has direct functional impact — it means a return to work, reduced consumption of analgesics, and lower risk of medication-overuse headache. The data showing that 57% of patients treated with acupuncture obtained significant reduction in attacks versus 46% with isolated pharmacotherapy positions the procedure as a first-line option in specific contexts: patients with contraindication to beta-blockers, valproate, or topiramate, pregnant women, and those who refuse continuous medication. This expansion of the prophylactic arsenal has direct relevance in the pain outpatient clinic.
Notable Findings
Two findings deserve special attention. First, the superiority of true acupuncture over sham, with 50% responders versus 41% in the control — data that weakens the argument that the effect is purely expectational and points to genuine neurophysiological modulation. Second, the findings from functional neuroimaging and magnetic resonance spectroscopy are particularly relevant from the mechanistic point of view: the increase in thalamic N-acetylaspartate correlated with reduction in pain intensity suggests that acupuncture interferes with central nociceptive processing circuits — a structure known to be compromised in migraine pathophysiology. This converges with the central sensitization model that we routinely use to explain chronification. The lower risk of adverse events versus pharmacotherapy (risk difference −0.16) also supports its incorporation even in vulnerable populations.
From My Experience
In my practice in the pain outpatient clinic, chronic migraine is one of the indications where I have the most confidence in acupuncture as an adjunct prophylactic tool. I usually observe a measurable response — subjective reduction in frequency and intensity reported by the patient — between the fourth and sixth sessions, which aligns with the minimum threshold of 6 to 8 sessions discussed in this review. My usual protocol provides for 10 to 12 sessions in the acute phase, with monthly maintenance afterward for patients with a history of recurrence. I systematically associate this with sleep hygiene guidance, trigger management, and, when there is a concomitant cervical tension component — which is the rule, not the exception — I integrate it with physical therapy focused on the suboccipital musculature. The profile that responds best, in my observation over the years, is the female patient of reproductive age, with menstrual or perimenstrual migraine, who tolerates neither hormonal therapy nor valproate. In these cases, acupuncture frequently allows the dose of the oral prophylactic to be reduced without loss of clinical control.
Dr. Marcus Yu Bin Pai · MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.
Full original article
Read the full scientific study
Neurology and Therapy · 2020
DOI: 10.1007/s40120-020-00216-1
Scientific review
Dr. Marcus Yu Bin PaiScientific lead · CRM-SP 158074 · RQE 65523 · 65524 · 655241
Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
- Strong
- Moderate
- Limited
- Weak
See the numbers: This study among the Library’s studies
| Study design | Headache & Migraine | All studies |
|---|---|---|
| Meta-analysis · Systematic Review | 23 | 387 |
| RCT | 15 | 224 |
| Clinical Guideline | 0 | 5 |
| Observational | 3 | 38 |
| Case Series | 0 | 7 |
| Narrative Review | 7 | 155 |
| Preclinical / Animal | 0 | 6 |
| Other | 11 | 203 |
Related articles
Based on this article’s categories
Facco et al. · Headache · 2008
- Headache & Migraine
- TCM Theory & Diagnostics
Cady & Farmer · Headache · 2015
- Headache & Migraine
- TCM Theory & Diagnostics
- Mechanisms of Action
Wang et al. · Journal of Oral & Facial Pain and Headache · 2024
- Headache & Migraine
- TCM Theory & Diagnostics
Wang et al. · Frontiers in Immunology · 2023
- Mechanisms of Action
- TCM Theory & Diagnostics